Chris OBrien is the CEO of Biorasi, a CRO focused on emerging biotech and pharma. An MBA graduate from The Tuck School of Business at Dartmouth, people describe him as poised, articulate, and personable. He actively explores industry trends by interviewing life sciences innovators on his podcast, "Few & Far Between. "
Chris has over 20 years of experience leading high-performing teams and building operational excellence. His BA in English Studies from Middlebury College provides a strong foundation for his focus on effective team communication and partnership development, which he views as critical for success in the complex clinical research industry.
He hosts the "Few & Far Between" podcast, which covers trending topics and innovations in clinical research, specifically for rare and urgent diseases.
Read the full overview →They are not very likely to become strong advocates of your product or service They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical They focus on the results, but can still be quite procedural and analytical about how to get there
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.